Manhattan Scientifics Inc (MHTX)

[ssc]

That is good news. But here is an interesting piece of the article and one of the reasons why the stock is heading toward a penny:

The Company notes that enrollment for the second cohort is ongoing with results consistent with those reported at the meeting and that further studies will be needed to broaden the study population to fully characterize the diagnostic performance of the imaging agent.

Considering it took 2 years into the study to produce this interim result which includes 6 people, how long would you think it will take to get to the end with 15 total people plus the further studies the company said will be needed? And how much more cash (and dilution)?

Looks like ibx investors should be hoping for a magic potion that stops the aging process if they ever hope to profit from their investment here.